0001209191-23-046578.txt : 20230818
0001209191-23-046578.hdr.sgml : 20230818
20230818164618
ACCESSION NUMBER: 0001209191-23-046578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230816
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Darrel P.
CENTRAL INDEX KEY: 0001989794
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 231186418
MAIL ADDRESS:
STREET 1: C/O VIRACTA THERAPEUTICS, INC.
STREET 2: 2533 S. COAST HWY 101, SUITE 210
CITY: CARDIFF
STATE: CA
ZIP: 92007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viracta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2533 S COAST HWY 101
STREET 2: SUITE 210
CITY: CARDIFF
STATE: CA
ZIP: 92007
BUSINESS PHONE: 858-400-8470
MAIL ADDRESS:
STREET 1: 2533 S COAST HWY 101
STREET 2: SUITE 210
CITY: CARDIFF
STATE: CA
ZIP: 92007
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
FORMER COMPANY:
FORMER CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980501
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-16
0
0001061027
Viracta Therapeutics, Inc.
VIRX
0001989794
Cohen Darrel P.
C/O VIRACTA THERAPEUTICS, INC.
2533 S. COAST HWY 101, SUITE 210
CARDIFF
CA
92007
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
1.23
2023-08-16
4
A
0
235000
0.00
A
2033-08-16
Common Stock
235000
235000
D
Stock Option (Right to Buy)
1.23
2023-08-16
4
A
0
265000
0.00
A
2033-08-16
Common Stock
265000
265000
D
Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.
Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.
/s/ Daniel Chevallard, as Attorny-in-Fact
2023-08-16